Results 121 to 130 of about 23,359 (243)

Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy

BMC Pediatrics, 2019
Background Adolescents with DMD treated with chronic high dose GC therapy typically have profound pubertal delay. Testosterone, the main circulating androgen in men, promotes virilisation and growth with associated accrual of fat-free muscle mass and ...
C. L. Wood, T. D Cheetham, K. G Hollingsworth, M. Guglieri, Y. Ailins-Sahun, S. Punniyakodi, A. Mayhew, V. Straub   +7 more
doaj   +1 more source

Recombinant follitropin alfa/lutropin alfa in fertility treatment

Biologics: Targets & Therapy, 2009
Ahmed Gibreel1, Siladitya Bhattacharya21School of Medicine and Dentistry, University of Aberdeen; 2Aberdeen Maternity Hospital, Aberdeen, UKAbstract: Recombinant human follicle stimulating hormone (rFSH) and luteinizing hormone (LH), also known as ...
Ahmed Gibreel, Siladitya Bhattacharya
doaj  

Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma

Cancer Medicine, 2019
Background Immune‐checkpoint inhibitors have been shown to improve survival in melanoma patients, but can also trigger immune‐related endocrinopathies, especially hypophysitis and thyroid dysfunction.
Eva Kassi, Anna Angelousi, Nikolaos Asonitis, Panagiotis Diamantopoulos, Amalia Anastasopoulou, George Papaxoinis, Michalis Kokkinos, Ilias Giovanopoulos, Georgios Kyriakakis, Fotini Petychaki, Akrivi Savelli, Olga Benopoulou, Helen Gogas   +12 more
doaj   +1 more source

Glucagon like pepetide-1 agonist in a patient with prader-willi syndrome: a Sri Lankan experience

Sri Lanka Journal of Diabetes Endocrinology and Metabolism, 2017
BackgroundPrader-Willi Syndrome (PWS) is a genetic disease characterized by morbid obesity and hyperphagia. Although the exact pathophysiological basis of obesity and hyperphagia remains unclear it is thought to be mainly due to hypothalamic dysfunction.
Maulee Hiromi Arambewela, Noel P. Somasundaram   +1 more
doaj   +1 more source

Haemoglobinopathies care and cure: Have we reached the end?

Thalassemia Reports, 2018
Recent years have seen accelerating advances in the treatment, monitoring and potential cures for haemoglobin disorders, as the interaction between basic science, pharmaceutical research, and practical medicine intensifies.
John Porter
doaj   +1 more source

GONADOTROPHIN RESPONSES TO GnRH PULSES IN HYPOGONADOTROPHIC HYPOGONADISM: LH RESPONSIVENESS IS MAINTAINED IN THE PRESENCE OF LUTEAL PHASE CONCENTRATIONS OF OESTROGEN AND PROGESTERONE [PDF]

, 1987
Todd B. Nippoldt, Sleman Khoury, Ariel L. Barkan, Robert P. Kelch, John C. Marshall   +4 more
openalex   +1 more source

NOCTURNAL PULSATILE LH SECRETION IN PREPUBERTY AND HYPOGONADOTROPHIC HYPOGONADISM ASSESSED BY A HIGHLY SENSITIVE IMMUNORADIOMETRIC ASSAY (IRMA) [PDF]

, 1988
F.C.W. Wu, C.J.H. Kelnar, Gary Butler, Robin Sellar   +3 more
openalex   +1 more source

Testicular dysfunction in men with primary hypothyroidism; reversal of hypogonadotrophic hypogonadism with replacement thyroxine [PDF]

, 2000
P Donnelly, Chris White
openalex   +1 more source

Kallmann syndrome and deafness: an uncommon combination: A case report and a literature review

Iranian Journal of Reproductive Medicine, 2016
Background: Kallmann syndrome (Kal S) is an isolated form of hypogonadotrophic hypogonadism in combination with a defect in smell sensation. Depending on the genetic form of the disease, a number of non-reproductive, non-olfactory abnormalities may also ...
Nader Salama
doaj  

Hypogonadotrophic hypogonadism, short stature, cerebellar ataxia, rod-cone retinal dystrophy, and hypersegmented neutrophils: a novel disorder or a new variant of Boucher-Neuhauser syndrome? [PDF]

, 2003
A-K Jbour
openalex   +1 more source